Organ preservation has long relied on a deceptively simple approach: flush the organ with a cold solution and pack it in ice. That method, known as static cold storage, remains the global workhorse, but it imposes tight time limits that force transplant teams into logistical sprints and leave many donated organs unused. Over the past decade, a wave of machine perfusion technologies, subzero storage strategies, and bioengineered additives has begun to change what is possible, extending preservation windows from hours toward days and turning previously unusable organs into transplantable ones.
Static Cold Storage and Its Limits
The basic idea behind static cold storage is metabolic slowdown. Cooling an organ to around 4°C drops its metabolic rate dramatically, buying time between retrieval and transplant. The technique is cheap, portable, and well understood, which is why it has been the default for decades. A heart can typically tolerate about four to six hours on ice, a liver roughly twelve, and a kidney up to about twenty-four hours before function starts to deteriorate meaningfully.
The problem is that cold itself causes injury. Cells swell as ion pumps lose energy and fail. Mitochondria accumulate metabolic byproducts, particularly succinate, which sets the stage for a burst of damaging molecules the moment warm blood flows back in. The preservation solutions used to flush organs before cooling contain protective compounds, but their components can also introduce a degree of toxicity. And after transplantation, reperfusion injury compounds whatever damage occurred during the cold period.
These overlapping insults are collectively known as ischemia-reperfusion injury, or IRI, and they represent the single biggest obstacle in organ preservation. IRI involves mitochondrial dysfunction, oxidative stress, inflammation, and cell death pathways including ferroptosis, a form of iron-dependent cell damage that has recently attracted attention as a therapeutic target.1PubMed Central. Ischaemia-Reperfusion Injury in Organ Transplantation: Role of Coenzyme Q10 At reperfusion, reactive oxygen species are immediately released from the mitochondrial respiratory chain, initiating a cascade of inflammation that can compromise or destroy the graft.2PubMed. Mitochondria and ischemia reperfusion injury Every preservation strategy ultimately aims to minimize this cascade.
Machine Perfusion at Varying Temperatures
Rather than storing an organ in a static bath, machine perfusion continuously pumps a solution through its blood vessels. This keeps the organ’s environment more controlled, clears waste products, and can deliver oxygen and nutrients. Perfusion systems come in several temperature categories, each with trade-offs.
Hypothermic machine perfusion operates near the same temperatures as cold storage but adds continuous flow. It has proven especially useful for kidneys, where it reduces the rate of delayed graft function compared to static storage. Hypothermic oxygenated perfusion, sometimes abbreviated HOPE, applies oxygen to a cold-perfused organ, helping mitochondria maintain a more functional state before transplantation.
Normothermic machine perfusion, performed at or near body temperature, takes a different approach entirely. Instead of slowing metabolism to a crawl, it keeps the organ fully metabolically active outside the body. The organ functions almost as if it were still inside the donor, consuming oxygen and producing bile (in the case of a liver) or urine (for a kidney). This has two major advantages. First, it allows clinicians to measure organ function in real time, essentially auditioning the graft before committing a patient to surgery. High-risk liver grafts, for example, have been successfully transplanted after viability assessment during normothermic perfusion.3PubMed. Viability assessment and transplantation of extended criteria donor liver grafts using normothermic machine perfusion Second, because the organ remains warm and active, certain types of cold injury are avoided altogether. While researchers acknowledge that the behavior of organs during normothermic perfusion is not yet fully understood, initial data in both kidneys and livers have been promising enough to shift clinical practice.4Transplant International. Sense and Sensibilities of Organ Perfusion as a Kidney and Liver Viability Assessment Platform
Organ-Specific Perfusion Advances
Different organs respond to preservation insults in different ways, and some of the most dramatic recent progress has been organ-specific.
Lungs
Lungs are unusually fragile grafts. They are exposed to the outside environment through ventilation, making them susceptible to infection and inflammation in the donor, and many otherwise healthy donor lungs are rejected because they fail standard assessment criteria. Ex vivo lung perfusion, or EVLP, has emerged as a way to evaluate and rehabilitate lungs that would otherwise be discarded.5PubMed Central. Ex vivo lung perfusion: recent advancements and future directions The lungs are connected to a ventilator and a perfusion circuit outside the body, where clinicians can monitor gas exchange, compliance, and other metrics over several hours. In some cases, EVLP has also been used to deliver therapies directly to the organ. One early report described using a clot-dissolving agent called urokinase during EVLP to clear blood clots from donor lungs, enabling a successful bilateral transplant from a graft that would have been discarded under conventional criteria.6PubMed. Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system
Hearts
Heart preservation has historically been one of the most time-sensitive challenges because the myocardium tolerates ischemia poorly. Ex vivo heart perfusion keeps the heart beating in a warm, oxygenated state during transport, and it has enabled expansion of the donor pool with outcomes comparable to standard cold storage.7PubMed Central. Heart transplant advances: Ex vivo organ-preservation systems This technology has been particularly important for hearts donated after circulatory death, which by definition have already endured a period of warm ischemia. More recently, experimental work has explored adding targeted drugs during normothermic ex vivo heart perfusion. In a rat model, adding a ferroptosis inhibitor called lipostatin-1 during perfusion improved post-transplant cardiac function and reduced cell damage in hearts that had undergone warm ischemia.8PubMed. Improved DCD Heart Transplant Function Through Ferroptosis Blockade in a Model of Experimental Normothermic Ex Vivo Perfusion
Subzero Preservation Without Ice
The biggest limitation of cold storage is the narrow window it provides. Going colder would slow metabolism further, but once you drop below 0°C you risk ice formation, and ice crystals are lethal to cells. Two research strategies aim to exploit subzero temperatures without allowing ice to form.
Supercooling involves carefully lowering an organ’s temperature below its freezing point while preventing ice nucleation, the formation of the first tiny ice crystals that would trigger a chain reaction. The technique has shown survival in animal models after preservation at −6°C for up to four days.9PubMed Central. Subzero organ preservation: the dawn of a new ice age? For human livers, a supercooling protocol has been developed that averts ice formation by minimizing air-liquid interfaces (which are common starting points for ice crystals) and pretreating the tissue with cryoprotective agents to lower the freezing point. Using this approach, human livers have been stored ice-free at −4°C, substantially extending their shelf life outside the body.10PubMed Central. Subzero non-frozen preservation of human livers in the supercooled state
A related but distinct approach is isochoric supercooling, which uses a sealed, rigid container filled completely with liquid so the volume cannot change. Because water expands when it freezes, the constant-volume constraint raises the thermodynamic barrier to ice formation, making the supercooled state more stable without requiring cryoprotectant chemicals. In laboratory tests, pig liver tissue has been maintained in this state for 24 and 48 hours without ice nucleation.11PubMed Central. Isochoric Supercooling Organ Preservation System Histological examination afterward showed that supercooled liver tissue maintained a normal appearance even after 48 hours, while tissue that had been allowed to freeze to −2°C was severely disrupted after just 24 hours.12Biochemistry and Biophysics Reports. An exploratory study on isochoric supercooling preservation of the pig liver This is still early-stage work, but the ability to preserve a whole organ at subzero temperatures in an isotonic solution without adding potentially toxic cryoprotectants would be a significant practical advantage.
Vitrification and the Nanowarming Problem
If supercooling is about staying just below zero, vitrification goes to the opposite extreme: cooling tissue so rapidly, using high concentrations of cryoprotectants, that it solidifies into a glass-like state rather than forming crystals. In principle, a vitrified organ could be stored indefinitely at liquid nitrogen temperatures. The problem has always been rewarming. Conventional warming from the outside heats unevenly, with the surface thawing faster than the core. As sections reach different temperatures, ice crystals form in the warming zones and crack the brittle vitrified tissue.
Nanowarming tackles this by distributing iron oxide nanoparticles throughout the organ’s vascular network along with the cryoprotectant solution. When an alternating magnetic field is applied, the nanoparticles generate heat throughout the tissue simultaneously. This produces rapid, uniform rewarming. In one series of experiments, nanowarming achieved temperature rise rates above 130°C per minute across volumes up to 80 milliliters, and the viability of rewarmed cells and tissues matched or exceeded that of conventionally warmed controls.13PubMed Central. Improved Tissue Cryopreservation using Inductive Heating of Magnetic Nanoparticles Whole rat hearts have been perfused with a magnetic cryopreservation agent, vitrified, stored in liquid nitrogen for a week, and then nanowarmed under an alternating magnetic field, with successful recovery of the vasculature.14PubMed Central. Perfusion, cryopreservation, and nanowarming of whole hearts using colloidally stable magnetic cryopreservation agent solutions Scaling this to full-size human organs is a major remaining challenge, but the proof of concept is further along than many people realize.
Treating Organs Outside the Body
Machine perfusion does not just keep an organ alive; it creates a unique window for therapy. Because the organ is isolated from the rest of the body’s immune and circulatory systems, drugs or biological agents can be delivered at concentrations that would be toxic or impractical if given to a patient systemically. This has opened the door to several experimental approaches.
Gene therapy delivered during ex vivo perfusion is one of the most ambitious. The idea is to modify the donor organ’s gene expression before transplantation, potentially making it less immunogenic or more resistant to injury. Normothermic perfusion platforms have been identified as an unprecedented setting for administering gene therapies to organs in an isolated manner.15PubMed Central. Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation If this works at scale, it could reduce the need for lifelong immunosuppression after transplant, which is responsible for many long-term complications including infections and cancers.
Even without gene therapy, perfusion systems are being used to deliver simpler treatments. Oxygen carriers derived from marine organisms have shown promise as perfusate additives. The hemoglobin of the lugworm Arenicola marina, for instance, carries oxygen effectively and has demonstrated anti-inflammatory and antioxidant properties. As a supplement to conventional preservation solutions, it has shown the ability to reduce ischemia-reperfusion injury in preclinical studies.16PubMed Central. Therapeutic Potential of Hemoglobin Derived from the Marine Worm Arenicola marina (M101): A Literature Review of a Breakthrough Innovation
Measuring Whether an Organ Will Work
One of the underappreciated benefits of perfusion technology is that it turns preservation into a diagnostic process. When an organ sits on ice, you can measure very little about how it will perform once transplanted. When it is on a perfusion circuit, you can track metabolic markers in real time. For livers, bile production and composition during normothermic perfusion have become key indicators. For kidneys, researchers are investigating biomarkers in the perfusate fluid that might predict whether a graft will function immediately or experience delayed recovery.
In a pilot study of kidneys undergoing normothermic perfusion, levels of flavin mononucleotide measured at 60 minutes were significantly higher in grafts that later developed delayed function or failed entirely compared to those that worked well.17PubMed Central. Flavin Mononucleotide as a Biomarker of Organ Quality-A Pilot Study If validated in larger studies, biomarkers like this could let transplant teams make go/no-go decisions with far more confidence, reducing the number of organs that are transplanted only to fail and sparing patients from unnecessary surgery.
Expanding the Donor Pool
All of these technologies converge on a shared practical goal: using more of the organs that are already donated. The shortage of transplantable organs is severe worldwide, and a significant fraction of donated organs are currently declined because they come from older donors, donors with fatty livers, donors whose hearts stopped before retrieval (donation after circulatory death), or situations involving prolonged warm ischemia time. Machine perfusion has allowed transplant centers to push beyond these traditional cutoffs. Centers using perfusion have accepted more donors after circulatory death, older donors, and livers with higher levels of fat infiltration than they otherwise would have.18PubMed. Liver machine perfusion technology: Expanding the donor pool to improve access to liver transplantation For hearts, normothermic perfusion and hypothermic perfusion have enabled retrieval of donor hearts that were not suitable for conventional ice storage, expanding the pool for adult heart transplantation.19Current Transplantation Reports. Expanding Donor Heart Utilization Through Machine Perfusion Technologies
This matters enormously. The difference between a patient dying on a waiting list and receiving a transplant often comes down to whether a borderline organ is accepted or declined. Tools that allow clinicians to assess and rehabilitate marginal organs in real time change that calculus.
The Economics of Better Preservation
Machine perfusion devices are expensive. The hardware, disposable circuits, perfusate solutions, and specialized personnel all add upfront cost compared to a cooler full of ice. This has been the most common objection from hospital administrators. But the economics look different when you account for what happens downstream. An analysis of hypothermic oxygenated perfusion for liver transplantation, compared to cold storage alone, found that HOPE reduced initial post-transplant hospital stay, biliary complications, re-transplantation rates, and deaths, translating to an estimated one-year cost reduction of roughly $29,000 per transplant. For organs donated after circulatory death, the savings were even larger, around $64,000 per case.20American Journal of Transplantation. Economic Assessment of Hypothermic Oxygenated Machine Perfusion in Liver Transplantation
Beyond the direct cost savings from fewer complications, machine perfusion generates value by transplanting patients earlier. A patient who receives a transplant sooner avoids further clinical deterioration while waiting, along with the costs of continued dialysis, repeated hospital admissions, and other supportive care.21PubMed. The economic impact of machine perfusion technology in liver transplantation When all of these factors are weighed, the technology is highly likely to be cost-effective despite its price tag.
Preservation Challenges in Xenotransplantation
Xenotransplantation, the transplantation of organs from one species to another, introduces preservation problems that do not exist in human-to-human transplants. Porcine organs appear unusually sensitive to ischemia-reperfusion injury when exposed to a recipient’s immune system across species barriers. In pig-to-primate kidney experiments, all grafts preserved with standard cold storage experienced hyperacute rejection within 90 minutes of reperfusion, even when the recipients had low levels of preformed antibodies against pig tissue. In contrast, kidneys preserved with hypothermic machine perfusion reperfused without clinical signs of injury and maintained function for more than 14 days.22PubMed Central. Hypothermic machine perfusion prevents hyperacute graft loss in pig-to-primate kidney xenotransplantation after 5-hours of cold Ischemia
A similar pattern has been observed in heart xenotransplantation. In pig-to-baboon experiments using genetically modified donor pigs, standard ischemic cardioplegia caused severe cardiac dysfunction and led to multi-organ failure in more than half of cases. Cold non-ischemic continuous perfusion with an oxygenated solution reliably prevented early graft failure.23PubMed. Cold non-ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig-to-baboon xenotransplantation The implication is clear: if xenotransplantation ever reaches routine clinical use, it will almost certainly require perfusion-based preservation rather than simple cold storage.
Logistics, Tracking, and the Cold Chain
Preservation science can produce a perfectly conditioned organ that fails because something went wrong during transport. Temperature excursions, delays, and miscommunication between retrieval and transplant teams remain real problems. Researchers have begun developing smart monitoring frameworks that use internet-connected sensors to track temperature, humidity, and other conditions in real time during transport. In one prototype system, sensor data is recorded every five seconds and stored on a decentralized file system, with automated alerts generated when conditions deviate from safe parameters.24PubMed Central. Smart traceable framework for transportation of transplantable organs using IPFS, iot, and smart contracts This kind of granular traceability could also help transplant teams make better decisions on the receiving end, because they would know exactly what the organ experienced during transit rather than relying on timestamps and assumptions.
Machine perfusion itself has logistical implications for equity. Current organ allocation systems are heavily influenced by geography and ischemic time limits, which means patients near large transplant centers tend to get organs faster. By extending preservation times, perfusion technologies could decouple organ allocation from geography and reduce these disparities.25Voices in Bioethics. Leveraging Machine Perfusion to Ameliorate Geographic Disparities in Organ Allocation
Antifreeze Proteins and Biomimetic Cryoprotection
Nature solved the problem of surviving subzero temperatures long before humans built perfusion machines. Fish, insects, and plants that live in extreme cold produce antifreeze proteins that bind to nascent ice crystals and prevent them from growing. Understanding how these proteins work at a molecular level could help improve the availability of donor organs for transplantation by offering a new class of preservation additives.26PubMed Central. From the freezer to the clinic: Antifreeze proteins in the preservation of cells, tissues, and organs
Research over the past three decades, primarily in reproductive medicine and sperm cryopreservation, has confirmed that antifreeze proteins can improve outcomes in low-temperature preservation. The beneficial effects have been consistent enough to support their use in both human and veterinary applications, and recent work has explored combining different types of antifreeze proteins with each other or with antioxidants to boost their effectiveness.27Theriogenology. Antifreeze proteins for low-temperature preservation in reproductive medicine: A systematic review over the last three decades Translating these findings from cells and small tissue samples to whole organs remains a significant step, but the concept of biomimetic cryoprotection, learning cold tolerance from organisms that already have it, is one of the more creative threads in the field.
Pediatric and Size-Matched Graft Preservation
Children needing transplants face a different set of preservation challenges. Pediatric organs are smaller, their blood vessels are finer, and size-matched donors are rare. When adult organs are split or reduced to fit a child, the resulting technical variant graft has cut surfaces and altered vascular anatomy that make it more vulnerable to ischemia-reperfusion injury.28PubMed. Machine perfusion of pediatric and technical variant liver grafts Adapting machine perfusion circuits for these smaller, irregularly shaped grafts is an active area of development. The pumps, tubing, and perfusate volumes designed for adult organs do not simply scale down, and the margin for error in perfusion pressure is narrower when the vasculature is tiny. Getting this right matters, because children who receive a transplant early in life need that graft to last for decades.